|
SAMD4A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.92239999999533E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.04260000002954E-06 |
| Normal-vs-Stage2 |
2.710100E-02 |
| Normal-vs-Stage3 |
3.174300E-02 |
| Normal-vs-Stage4 |
1.810440E-01 |
| Stage1-vs-Stage2 |
7.474600E-01 |
| Stage1-vs-Stage3 |
1.753570E-01 |
| Stage1-vs-Stage4 |
8.033600E-04 |
| Stage2-vs-Stage3 |
5.701800E-01 |
| Stage2-vs-Stage4 |
1.511640E-01 |
| Stage3-vs-Stage4 |
2.715400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.780000E-04 |
| Normal-vs-AfricanAmerican |
7.016400E-04 |
| Normal-vs-Asian |
7.466200E-02 |
| Caucasian-vs-AfricanAmerican |
2.346200E-01 |
| Caucasian-vs-Asian |
7.552400E-01 |
| AfricanAmerican-vs-Asian |
8.694000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.161000E-03 |
| Normal-vs-Female |
2.08329999999979E-05 |
| Male-vs-Female |
2.600200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.240310E-02 |
| Normal-vs-Age(41-60Yrs) |
3.58910000000101E-05 |
| Normal-vs-Age(61-80Yrs) |
3.599500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.274400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.572800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.390400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.799200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.349150E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.164200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.572400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.8038000000018E-05 |
| Normal-vs-Grade 2 |
2.7919999999737E-06 |
| Normal-vs-Grade 3 |
1.344340E-02 |
| Normal-vs-Grade 4 |
5.534000E-01 |
| Grade 1-vs-Grade 2 |
4.800200E-02 |
| Grade 1-vs-Grade 3 |
6.042800E-03 |
| Grade 1-vs-Grade 4 |
1.028880E-04 |
| Grade 2-vs-Grade 3 |
5.844000E-03 |
| Grade 2-vs-Grade 4 |
4.37770000000226E-05 |
| Grade 3-vs-Grade 4 |
5.875600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.89502999999869E-05 |
| Normal-vs-ccB subtype |
1.062530E-03 |
| ccA subtype-vs-ccB subtype |
2.806800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.395100E-04 |
| Normal-vs-N1 |
7.036400E-01 |
| N0-vs-N1 |
7.544400E-03 |
|
|
